Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Large Vessel Occlusion Stroke
NCT07912970Phase 3Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Apr 2027
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Functional Independence (mRS 0-2) at 90 days. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07912970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07912970.